Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization

Translational Oncology

Volumn 4, Issue 1, 2011, Pages 29-37

  Aguirre, Andres ^a   Ardeshirpour, Yasaman ^a   Sanders, Mary M ^b   Brewer, Molly ^b   Zhu, Quing ^a  

^a University of Connecticut   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIGHT ABSORPTION; OVARY CANCER; PHOTOACOUSTIC SPECTROSCOPY; POSTMENOPAUSE;

EID: 79251590303     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.10187     Document Type: Article

References (33)

1. Hoskins WJ (1995). Prospective on ovarian cancer: why prevent? J Cell Biochem Suppl 23, 189-199.
2. American Cancer Society (2009). Cancer facts & figures 2009. American Cancer Society 72.
3. U.S. Preventive Services Task Force (2004). Screening for Ovarian Cancer: Recommendation Statement. http://www.uspreventiveservicestaskforce.org/3rduspstf/ovariancan/ovcanrs.htm.
4. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, et al. (2002). Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21), 1609-1615.
5. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, et al. (2002). Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346(21), 1616-1622.
6. Fatouros M, Baltoyiannis G, and Roukos DH (2008). The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations. Ann Surg Oncol 15(1), 21-33.
7. Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA, et al. (2008). Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 26(8), 1331-1337.
8. NIH Consensus Conference (1995). Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 273(6), 491-497.
9. Tammela J and Lele S (2004). New modalities in detection of recurrent ovarian cancer. Curr Opin Obstet Gynecol 16(1), 5-9
10. Nossov V, Amneus M, Su F, Lang J, Janco JM, Reddy ST, and Farias-Eisner R (2008). The early detection of ovarian cancer: from traditional methods to proteo-mics. Can we really do better than serum CA-125? Am J Obstet Gynecol 199(3), 215-223.
11. Goozner M (2010). Personalizing ovarian cancer screening. J Natl Cancer Inst 102(15), 1112-1113.
12. Shaaban A and Rezvani M (2009). Ovarian cancer: detection and radiologic staging. Clin Obstet Gynecol 52(1), 73-93.
13. Funt SA and Hricak H (2003). Ovarian malignancies. Top Magn Reson Imaging 14(4), 329-337.
14. Bristow RE, Giuntoli RL, Pannu HK, Schulick RD, Fishman EK, and Wahl RL (2005). Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Gynecol Oncol 99(2), 294-300.
15. Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber WA, Werner M, Graeff H, Schwaiger M, and Kuhn W (2005). Prediction of response to neoad-juvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol 23(30), 7445-7453.
16. Nakamoto Y, Saga T, and Fujii S (2005). Positron emission tomography application for gynecologic tumors. Int J Gynecol Cancer 15(5), 701-709.
17. Kumar R, Chauhan A, Jana S, and Dadparvar S (2006). Positron emission tomography in gynecological malignancies. Expert Rev Anticancer Ther 6(7), 1033-1044.
18. Li C and Wang LV (2009). Photoacoustic tomography and sensing in biomed-icine. Phys Med Biol 54(19), R59-R97.
19. Oraevsky A and Karabutov A (2003). Optoacoustic tomography. In Biomedical Photonics Handbook. T Vo-Dinh (Ed). CRC Press, Boca Raton, FL. p. 34.
20. Wang LV (2008). Prospects of photoacoustic tomography. Med Phys 35, 5758-5767.
21. Xu M and Wang L (2006). Photoacoustic imaging in biomedicine. Rev Sci Instrum 77(4), 041101.
22. Weidner N, Semple JP, Welch WR, and Folkman J (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324(1), 1-8.
23. Vaupel P, Kallinowski F, and Okunieff P (1989). Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23), 6449-6465.
24. Brewer MA, Utzinger U, Barton JK, Hoying JB, Kirkpatrick ND, Brands WR, Davis JR, Hunt K, Stevens SJ, and Gmitro AF (2004). Imaging of the ovary. Technol Cancer Res Treat 3(6), 617-627.
25. Hariri LP, Bonnema GT, Schmidt K, Winkler AM, Korde V, Hatch KD, Davis JR, Brewer MA, and Barton JK (2009). Laparoscopic optical coherence tomography imaging of human ovarian cancer. Gynecol Oncol 114(2), 188-194.
26. Gamelin J, Aguirre A, Maurudis A, Huang F, Castillo D, Wang L, and Zhu Q (2008). Curved array photoacoustic tomographic system for small animal imaging. J Biomed Opt 13(2), 024007.
27. Aguirre A, Gamelin J, Guo P, Yan S, Sanders M, Brewer M, and Zhu Q (2009). Photoacoustic characterization of ovarian tissue. Proceedings of SPIE 7177(1), 717708.
28. Aguirre A, Guo P, Gamelin J, Yan S, Sanders MM, Brewer M, and Zhu Q (2009). Coregistered three-dimensional ultrasound and photoacoustic imaging system for ovarian tissue characterization. J Biomed Opt 14(5), 054014.
29. Z.1.3.6. Committee (2007). American National Standard for Safe Use of Lasers. Laser Institute of America, New York, NY.
30. Karst AM and Drapkin R (2010). Ovarian cancer pathogenesis: a model in evolution. J Oncol 2010, 932371.
31. Zhu Q, Chen N, and Kurtzman SH (2003). Imaging tumor angiogenesis by use of combined near-infrared diffusive light and ultrasound. Opt Lett 28(5), 337-339.
32. Zhu Q, Xu C, Guo P, Aguirre A, Yuan B, Huang F, Castilo D, Gamelin J, Tannenbaum S, Kane M, et al. (2006). Optimal probing of optical contrast of breast lesions of different size located at different depths by US localization. Technol Cancer Res Treat 5(4), 365-380.
33. Xu C, Yuan B, and Zhu Q (2008). Optimal probe design for breast imaging using near-infrared diffused light. J Biomed Opt 13(4), 044002.